Hjem › Idiopatisk pulmonal fibrose › California
Kliniske studier for Idiopatisk pulmonal fibrose i California
13 studier for Idiopatisk pulmonal fibrose søker deltakere på steder i California.
Byer i California
Offisiell studietekst (engelsk)
Remote Evaluation and Surveillance of Patients With Interstitial Lung Disease: Transforming ILD Care Delivery With Remote Monitoring
- University of California, San Francisco, San Francisco
Rekrutterer
Alder 18 og eldre · Alle kjønn · Oppdatert 5. okt. 2026 · NCT07673237An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
- University of Southern California, Los Angeles
- Newport Native MD, Inc., Newport Beach
RekruttererFase 2
Alder 18 og eldre · Alle kjønn · Oppdatert 2. okt. 2026 · NCT06951217A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
- Research Site, Loma Linda
- Research Site, Los Angeles
- Research Site, Newport Beach
- og 2 flere
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07652658RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Kadima Neuropsychiatry Institute, San Diego
- Providence Medical Foundation, Santa Rosa
RekruttererFase 2
Alder 18 til 80 · Alle kjønn · Oppdatert 15. sep. 2026 · NCT07002034Idiopathic Pulmonary Fibrosis (IPF)-Related Chronic Cough Reduction With Nalbuphine Extended-Release (NAL ER) Tablets
- Newportnativemd, Inc., Newport Beach
- Palmtree Clinical Research, Palm Springs
- Paradigm Clinical Research Centers, Inc. - Redding, Redding
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 14. sep. 2026 · NCT07671911A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
- University of Southern California, Los Angeles
- Cedars Sinai Medical Center, Los Angeles
- Paradigm Clinical Research Centers, LLC, San Diego
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06968845Trial to Evaluate the Efficacy and Safety of LYT-100 (Deupirfenidone) Compared to Pirfenidone in Adults With Idiopathic Pulmonary Fibrosis (IPF)
- Palmtree Clinical Research Inc., Palm Spring
- Paradigm Clinical Research Centers LLC, Redding
RekruttererFase 3
Alder 40 og eldre · Alle kjønn · Oppdatert 3. sep. 2026 · NCT07284602Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
- University of California San Francisco, San Francisco
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 2. sep. 2026 · NCT05571059Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry
- University of California - Los Angeles, Los Angeles
- University of Southern California, Los Angeles
- Stanford University, Stanford
RekruttererObservasjonsstudie
Alder 21 og eldre · Alle kjønn · Oppdatert 12. aug. 2026 · NCT01915511Dose-Escalation Study of Artesunate Patients With IPF
- Stanford University, Stanford
RekruttererFase 1
Alder 40 og eldre · Alle kjønn · Oppdatert 11. aug. 2026 · NCT05988463WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
- WISPer Site in Los Angeles, CA, Los Angeles
- WISPer site in Newport Beach, CA, Newport Beach
- WISPer Site in Palm Springs, CA, Palm Springs
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 10. aug. 2026 · NCT06967805Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis
- Keck School of Medicine of USC, Los Angeles
RekruttererFase 2
Alder 40 og eldre · Alle kjønn · Oppdatert 12. nov. 2025 · NCT05975983Zinc and Nicotinamide Riboside for Idiopathic Pulmonary Fibrosis
- Cedars-Sinai, Los Angeles
RekruttererFase 2
Alder 50 og eldre · Alle kjønn · Oppdatert 10. nov. 2025 · NCT06567717Fra ClinicalTrials.gov, data hentet 6. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.